Toxicity of E. coli L‐asparaginase in man

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Cancer

• Publication date

  1970-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-UPMID 4905153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen-antibody reactions in gels.

  2009cited by this paper
• Clinical results of treatment with E. coli L‐asparaginase in adults with leukemia, lymphoma, and solid tumors

  1970cited by this paper
• E. coli L‐asparaginase in the treatment of leukemia and solid tumors in 131 children

  1970cited by this paper
• L‐asparaginase activity in plasma and other biological fluids

  1970cited by this paper
• Book Review: Analytical methods for atomic absorption spectrophotometry. The Perkin-Elmer Corporation, Norwalk, Connecticut, 06852, U.S.A., 1968. $25.00 (looseleaf). Order as part number 303-0152

  1969cited by this paper
• Asparagine Synthetase Activity in Malignant and Non-malignant Human Kidney and Prostate Specimens

  1969cited by this paper
• Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109,229) treatment in man--a preliminary report.

  1969cited by this paper
• The toxicity of Escherichia coli L-asparaginase.

  1969cited by this paper
• L-asparaginase toxicity.

  1969cited by this paper
• Hepatic Lipidosis Associated with l-Asparaginase Treatment∗

  1969cited by this paper
• L-asparaginase and blastogenesis.

  1969cited by this paper
• [Inhibition of malignant human neoplasms with L-asparaginase].

  1969cited by this paper
• [Immunosuppressive effect of L-asparaginase in the graft-versus-host reaction].

  1969cited by this paper
• Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy.

  1969cited by this paper
• [On the enzyme therapy of leukemias].

  1968cited by this paper
• Zur Enzymtherapie der Leukämien

  1968cited by this paper
• STUDIES ON THE MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE

  1968cited by this paper
• Inhibition of HeLa cell cultures by preparations of Escherichia coli L-asparaginase.

  1968cited by this paper
• Asparagine Synthetase Activity of Mouse Leukemias

  1968cited by this paper
• Embryotoxic Effect of L-Asparaginase

  1968cited by this paper
• Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase.

  1968cited by this paper
• Differences in the production of L-asparagine in asparaginase-sensitive and resistant lymphoma cells.

  1967cited by this paper
• [Bacterial endotoxins].

  1967cited by this paper
• Inhibition of leukemias in man by L-asparaginase.

  1967cited by this paper
• L-asparagine biosynthesis by nutritional variants of the Jensen sarcoma.

  1967cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• L-Asparaginase: Inhibition of Early Mitosis in Regenerating Rat Liver

  1967cited by this paper
• L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.

  1967cited by this paper
• Treatment of lymphosarcoma in the dog with L‐asparaginase

  1967cited by this paper
• Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

  1967cited by this paper
• SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE

  1967cited by this paper
• Automated Techniques in Lipid Chemistry

  1967cited by this paper
• Serum 5′‐nucleotidase in patients with tumor in the liver

  1966cited by this paper
• Dietary requirement for asparagine and its metabolism in rats.

  1966cited by this paper
• AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA.

  1965cited by this paper
• The metabolic effects in man of bovine growth hormone digested with trypsin.

  1965cited by this paper
• Serum 5′‐nucleotidase in patients with cancer

  1965cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS

  1963cited by this paper
• MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS

  1963cited by this paper
• EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS

  1963cited by this paper
• MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS : I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY

  1963cited by this paper
• Application of a microtechnique to viral serological investigations.

  1962cited by this paper
• The incorporation of [14C]leucine into serum albumin by the isolated microsome fraction from rat liver

  1962cited by this paper
• The incorporation of [C]leucine into serum albumin by the isolated microsome fraction from rat liver.

  1962cited by this paper
• Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

  1961cited by this paper
• Rapid Estimation of Fibrinogen

  1961cited by this paper
• Comparison of serum alkaline phosphatase activities determined with sodium beta-glycerophosphate and sodium phenylphosphate as substrates.

  1960cited by this paper
• Adaptation of an alkaline phosphatase method for automatic colorimetric analysis.

  1959cited by this paper
• [Hemorrhagic diseases].

  1958cited by this paper
• Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine.

  1956cited by this paper
• Transaminase activity in human blood.

  1955cited by this paper
• RABBIT RESPONSES TO HUMAN THRESHOLD DOSES OF A BACTERIAL PYROGEN

  1954cited by this paper
• REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM

  1953cited by this paper
• Intracorneal murine leprosy and its response to isoniazid.

  1953cited by this paper
• The accumulation, interpretation, and presentation of data pertaining to metabolic balances, notably those of calcium, phosphorus, and nitrogen.

  1945cited by this paper
• THE DETERMINATION OF URIC ACID IN HUMAN BLOOD

  1945cited by this paper
• Determination of bromsulphalein in normal, turbid, hemolyzed, or icteric serums.

  1945cited by this paper
• The direct biuret method for the determination of serum proteins as applied to photoelectric and visual colorimetry.

  1942cited by this paper
• A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE

  1937cited by this paper
• THE DETERMINATION OF BILIRUBIN WITH THE PHOTOELECTRIC COLORIMETER

  1937cited by this paper
• CLINICAL ESTIMATION AND SIGNIFICANCE OF CALCIUM‐ION CONCENTRATIONS IN THE BLOOD

  1935cited by this paper
• A MICROMETHOD FOR THE DETERMINATION OF FREE AND COMBINED CHOLESTEROL

  1934cited by this paper

• Engineered L-asparaginase variants with enhanced therapeutic properties to improve treatment of childhood acute lymphatic leukemia

  2025cites this paper
• Rare Pancreatitis-Related Complications of L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia: A Case With Pseudocyst and Panniculitis and Literature Review.

  2025cites this paper
• Emerging advancements to improve L-asparaginase-based therapy: New insight into old paradigm, a review.

  2025cites this paper
• Induction of Cyp2e1 contributes to asparaginase-induced hepatocyte sensitization to lipotoxicity

  2024cites this paper
• Cinchonain Ia Shows Promising Antitumor Effects in Combination with L-Asparaginase-Loaded Nanoliposomes

  2023cites this paper
• Apoptosis and cell cycle arrest of leukemic cells by a robust and stable L-asparaginase from Pseudomonas sp. PCH199.

  2023cites this paper
• Associations of T-Cell Receptor Repertoire Diversity with L-Asparaginase Allergy in Childhood Acute Lymphoblastic Leukemia

  2023cites this paper
• Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes.

  2023cites this paper
• Engineering antigen-specific tolerance to an artificial protein hydrogel

  2023cites this paper
• BLCTT_A_342052 55..79

  2022cites this paper
• Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance

  2022cites this paper
• Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy

  2022cites this paper
• L-asparaginase e perspectivas no tratamento da leucemia linfoblástica aguda: revisão de literatura

  2022cites this paper
• Human L‑asparaginase: Acquiring knowledge of its activation (Review).

  2021cites this paper
• Antineoplastic agents associated with the development of drug-induced pancreatitis

  2021cites this paper
• Erythrocyte-enabled immunomodulation for vaccine delivery.

  2021cites this paper
• Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice

  2021cites this paper
• Pharmacologic approaches to amino acid depletion for cancer therapy

  2021cites this paper
• Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management

  2020cites this paper
• Advances in Supportive Care for Acute Lymphoblastic Leukemia

  2020cites this paper
• Erythrocyte-derived drug delivery systems in cancer therapy

  2020cites this paper
• Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia

  2020cites this paper
• Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker

  2019cites this paper
• Asparaginase immune complexes induce Fc‐γRIII–dependent hypersensitivity in naive mice

  2019cites this paper
• Hypertriglyceridemia-Associated Drug-Induced Acute Pancreatitis

  2019cites this paper
• Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis

  2019cites this paper
• Nanoliposomal L-Asparaginase and Its Antitumor Activities in Lewis Lung Carcinoma Tumor-Induced BALB/c Mice

  2019cites this paper
• L-asparaginase produced from soil isolates of Pseudomonas aeruginosa shows potent anti-cancer activity on HeLa cells

  2019cites this paper
• What makes a good new therapeutic l-asparaginase?

  2019cites this paper
• Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII

  2018cites this paper
• Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen

  2018cites this paper
• Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent

  2017cites this paper
• METHOD FOR TREATMENT OF CANCERS OR NFLAMMATORY DISEASES Inventors:

  2017cites this paper
• Metabolic hijacking: A survival strategy cancer cells exploit?

  2017cites this paper
• Investigation of the mechanism of L-asparaginase-induced acute pancreatitis

  2017cites this paper
• OVERVIEW ON L-ASPARAGINASE

  2017cites this paper
• THERMOKINETIC STUDIES OF ANTI-LEUKEMIC L-ASPARAGINASE OF PSEUDOMONAS FLUORESCENS

  2017cites this paper
• Personalisation of dexamethasone in childhood acute lymphoblastic leukaemia

  2017cites this paper
• Outcomes Following Discontinuation of E. coli l‐Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia

  2016cites this paper
• Hypersensitivity reactions associated with L-asparaginase administration in 142 dogs and 68 cats with lymphoid malignancies: 2007-2012.

  2016cites this paper
• A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL08P1

  2016cites this paper
• L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL.

  2016cites this paper
• Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase

  2016cites this paper
• Incidence and Management of Toxicity Associated with LAsparaginase in the Treatment of ALL and NK/TCell Lymphoma: an Observational Study.

  2016cites this paper
• L-asparaginase in the treatment of patients with acute lymphoblastic leukemia

  2016cites this paper
• Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.

  2016cites this paper
• TOXICITIES OF LEUNASE (L – ASPARAGINASE) ADMINISTRATION IN NORMAL HEALTHY RABBITS

  2016cites this paper
• How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors

  2015cites this paper
• ALERGIJSKA REAKCIJA NA L - ASPARAGINAZU I ISHOD LIJEČENJA AKUTNE LIMFOBLASTIČNE LEUKEMIJE KOD DJECE

  2015cites this paper
• Seeking efficacy in L-asparaginase to combat acute lymphoblastic leukemia (ALL): A review

  2015cites this paper
• Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase

  2015cites this paper
• Haemostatic alterations induced by treatment with asparaginases and clinical consequences

  2014cites this paper
• Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia

  2014cites this paper
• HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

  2014cites this paper
• Important Sources and Medicinal Applications of L-Asparaginase

  2014cites this paper
• Isolation and Characterization of L-asparginase producing isolate from Lonar Lake, Buldhana District, MS, India

  2014cites this paper
• A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia

  2014cites this paper
• l-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia

  2014cites this paper
• Expression of CD203c on basophils as a marker of immunoglobulin E-mediated l-asparaginase allergy

  2014cites this paper
• allergies *07:01 is associated with a higher risk of asparaginase HLA-DRB1

  2014cites this paper
• Optimization of Media Components and Cultural conditions for L-asparginase production by a potent isolate from the unusual habitat of Lonar Lake, India

  2014cites this paper
• Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia

  2014cites this paper
• Human papillomavirus genotypes distribution in cervical samples from Uruguayan women

  2013cites this paper
• High-throughput asparaginase activity assay in serum of children with leukemia.

  2013cites this paper
• Hiperglicemiaenniñosconleucemialinfoblástica agudaentratamientoconL-asparaginasa

  2013cites this paper
• THE ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS IN IRAQI PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DURING THE INDUCTION PHASE

  2013cites this paper
• Erythrocytes: From Oxygen Delivery to Drug Delivery

  2012cites this paper
• Treatment of severe hypertriglyceridemia associated with accidental pegylated asparaginase push in a child with relapsed acute lymphoblastic leukemia

  2012cites this paper
• Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients

  2012cites this paper
• Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines

  2012cites this paper
• L-Asparaginase from Microbes: a Comprehensive Review

  2012cites this paper
• l-Asparaginase as Potent Anti-leukemic Agent and Its Significance of Having Reduced Glutaminase Side Activity for Better treatment of Acute Lymphoblastic Leukaemia

  2012cites this paper
• Erwinia asparaginase in pediatric acute lymphoblastic leukemia

  2012cites this paper
• Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?

  2011cites this paper
• Depressogenic effects of medications: a review

  2011cites this paper
• Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866)

  2011cites this paper
• Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity.

  2011cites this paper
• Role of L-Asparaginase as an Effective Chemotherapeutic agent for Acute Lymphoblastic Leukemia in Children’s

  2011cites this paper
• Transient Hyperammonemia Due to L -Asparaginase Therapy in Children with Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

  2011influential citation
• activity for cancer cell toxicity Rational engineering of L-asparaginase reveals importance of dual

  2011cites this paper
• Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?

  2011cites this paper
• Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia

  2011cites this paper
• L-asparaginase from marine derived fungal endophytes of seaweeds

  2011cites this paper
• Five‐year single‐center study of asparaginase therapy within the ALL‐BFM 2000 trial

  2011cites this paper
• Insulin Infusion to Treat Severe Hypertriglyceridemia Associated With Pegaspargase Therapy: A Case Report

  2011cites this paper
• Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel

  2011cites this paper
• l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial

  2011cites this paper
• Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia

  2010cites this paper
• Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity

  2010cites this paper
• Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte

  2010cites this paper
• Comparison between Two Erwinia carotovora L-Asparaginase II Constructions: cloning, Heterologous Expression, Purification, and Kinetic Characterization

  2010cites this paper
• Therapeutic drug monitoring of asparaginase in the ALL‐BFM 2000 protocol between 2000 and 2007

  2010influential citation
• The ex vivo production of ammonia predicts l-asparaginase biological activity in children with acute lymphoblastic leukemia

  2009cites this paper
• Pegasparaginase: where do we stand?

  2009cites this paper
• Parameter Optimization for Recombinant Asparaginase Production in Escherichia coli

  2009cites this paper
• Octreotide therapy in asparaginase‐associated pancreatitis in childhood acute lymphoblastic leukemia

  2008cites this paper
• Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.

  2008cites this paper
• Purification of recombinant Erwinia carotovora subsp. atroseptica L-Asparaginase II produced in Escherichia coli

  2008cites this paper
• A Case Report of an Adult With Severe Hyperlipidemia During Acute Lymphocytic Leukemia Induction Therapy Successfully Treated With Plasmapheresis

  2008cites this paper
• METHOD FOR TREATMENT OF CANCERS OR INFLAMMATORY DISEASES HELD OF THE INVENTION This invention relates to the use of a glycosylasparaginase polypeptide with L- asparaginase activity or its precursor in the treatment or prevention of cancers

  2008cites this paper